Zobrazeno 1 - 10
of 17
pro vyhledávání: '"Kiran, Garikapati"'
Autor:
Adrian daSilva-deAbreu, Kiran Garikapati, Bader Aldeen Alhafez, Sapna Desai, Clement Eiswirth, Selim Krim, Hamang Patel, Carl J. Lavie, Hector O. Ventura, Juan Francisco Loro-Ferrer, Stacy A. Mandras
Publikováno v:
BMC Research Notes, Vol 13, Iss 1, Pp 1-3 (2020)
Abstract Objectives Patients with end-stage heart failure (ESHF) treated with ventricular assist devices (VADs) tend to gain weight after implantation, which is associated with higher complication rates and is a contraindication for heart transplanta
Externí odkaz:
https://doaj.org/article/6018f0ec54b64754a6bdc54291e12a2d
Autor:
Koyenum Obi, Kiran Garikapati, Michael E. Cash, Patrick G. Parrino, Merrill H. Stewart, Salima Qamruddin
Publikováno v:
CASE. 6:421-424
Autor:
Tamunoinemi Bob-Manuel, Oscar Maitas, Justin Price, Abdullah Noor, Koyenum Obi, Nelson Okoh, Kiran Garikapati, Jeong Kim, Sanjida Jahan, James S. Jenkins
Publikováno v:
Current Cardiology Reviews. 19
Abstract: Patients with posterior circulation ischemia due to vertebral artery stenosis account for 20 to 25% of ischemic strokes and have an increased risk of recurrent stroke. In patients treated with medical therapy alone, the risk of recurrence i
Autor:
Hamang Patel, Selim R. Krim, Sapna Desai, Bader Aldeen Alhafez, Kiran Garikapati, Clement Eiswirth, Adrian daSilva-deAbreu, Stacy A. Mandras, Juan Francisco Loro-Ferrer, Carl J. Lavie, Hector O. Ventura
Publikováno v:
Obesity Surgery. 31:884-890
We analyzed in detail the outcomes of eight patients with ventricular assist devices (VADs) and obesity who underwent laparoscopic sleeve gastrectomy (LSG) at a single heart transplant (HT) center. This comprehensive analysis included body mass index
Autor:
Uzoma N. Ibebuogu, Tamunoinemi Bob-Manuel, Connor Gillies, Ivana Okor, Harith Baldawi, Kiran Garikapati
Publikováno v:
Current problems in cardiology. 46(12)
Rheumatic heart disease (RHD) mainly affects people in developing, low-income countries. However, due to globalization and migration, developed countries are now seeing more cases of RHD. In RHD patients who develop severe symptomatic aortic stenosis
Autor:
Juan Francisco Loro-Ferrer, Sapna Desai, Hamang Patel, Stacy A. Mandras, Adrian daSilva-deAbreu, Carl J. Lavie, Selim R. Krim, Hector O. Ventura, Kiran Garikapati, Clement Eiswirth, Bader Aldeen Alhafez
Publikováno v:
BMC Research Notes, Vol 13, Iss 1, Pp 1-3 (2020)
BMC Research Notes
BMC Research Notes
Objectives Patients with end-stage heart failure (ESHF) treated with ventricular assist devices (VADs) tend to gain weight after implantation, which is associated with higher complication rates and is a contraindication for heart transplantation (HT)
Autor:
Adrian, daSilva-deAbreu, Kiran, Garikapati, Bader Aldeen, Alhafez, Sapna, Desai, Clement, Eiswirth, Selim, Krim, Hamang, Patel, Hector O, Ventura, Carl J, Lavie, Juan Francisco, Loro-Ferrer, Stacy A, Mandras
Publikováno v:
Obesity surgery. 31(2)
We analyzed in detail the outcomes of eight patients with ventricular assist devices (VADs) and obesity who underwent laparoscopic sleeve gastrectomy (LSG) at a single heart transplant (HT) center. This comprehensive analysis included body mass index
Publikováno v:
Texas Heart Institute Journal. 43:65-68
Immunosuppression is the typical measure to prevent rejection after heart transplantation. Although rejection is the usual cause of cardiac hypertrophy, numerous other factors warrant consideration. Calcineurin inhibitors rarely cause hypertrophic ca
Autor:
Kiran Garikapati, Hector O. Ventura, Stacy A. Mandras, Selim R. Krim, Carl J. Lavie, Bader Aldeen Alhafez, Juan Francisco Loro-Ferrer, Clement Eiswirth, Sapna Desai, Hamang Patel, Adrian daSilva-deAbreu
Publikováno v:
Journal of Cardiac Failure. 26:S43
Background Sleeve gastrectomy (SG) may be a useful intervention to help obese patients with ventricular assist devices (VADs) to improve their candidacy for heart transplantation (HT). However, much remains unknown about perioperative adverse events,
Publikováno v:
Renal Failure. 35:1228-1235
Atrial fibrillation (AF) is emerging as a major health problem. The prevalence is as high as 32% in patients with renal disease. Gastrointestinal bleeding (GIB) is a frequent complication.To investigate the hazards of resumption or discontinuation of